ASCO Annual Meeting 2017 - Given the hurdles, the data is only “semi-sweet”: good enough for regulatory approval, but the toxicities seen in MONARCH 2, and abemaciclib’s eventual third-to-market introduction might cause physicians to question when to offer the agent.

Properly identifying market segments is an integral part of a launch excellence program. In the post, Richard Goosey reviews the “art and science” of market segmentation in healthcare and the need to activate and embed the segmentation among all stakeholders to achieve optimal success.

New research by Kantar Health, developed in South Korea has found that Patient Blog studies enable a much closer look into the real lives of patients than ever before and serve as a more effective means to understanding the increasingly important roles patients play in healthcare decision making.